*LRB10410584LAW20660r*Bill SR0105Text LRB104- 10584SR-103 LAWskip 20660to rcontent SENATEhome RESOLUTIONaccessibility WHEREAS,FAQ Seriousfeedback mentalsitemap illnesseslogin likex bipolarQuick disorder,Search: major depressive disorder, and schizophrenia often require treatment with antipsychotic medications for effective management, and antipsychotic prescribing rates continue to rise;

andBill WHEREAS,Number WhileBill prolongedKeyword antipsychoticHome useBill mayInformation beCalifornia essentialLaw forPublications theOther treatmentResources ofMy certainSubscriptions conditions,My itFavorites isBill associatedInformation with>> tardiveBill dyskinesiaSearch (TD),>> aText conditionBill markedText byPDF2 uncontrollable,Bill abnormal,PDF and|Add repetitiveTo movementsMy ofFavorites the|Track face,Bill torso,| limbs,Version: or extremities;

and05/05/26 WHEREAS,- PeopleEnrolled at04/27/26 higher- riskIntroduced ofSR-103 TD(2025-2026) includeText those>> olderVotes than>> 55History years,>> peopleBill whoAnalysis are>> Black,Today's women,Law individualsAs withAmended mood>> orCompare substanceVersions use>> disorders,Status intellectual>> disabilities,Comments orTo centralAuthor nervous>> systemTrack injuries,Bill and>> thoseAdd withTo highMy cumulativeFavorites antipsychotic>> exposure;SHARE THIS:

andSR103:v98#DOCUMENTBill WHEREAS,Start ApproximatelyEnrolled 60% May 05, 2026 ofPassed the IN  estimatedSenate 800,000 May 04, 2026 U.S.CALIFORNIA LEGISLATURE— 2025–2026 REGULAR SESSION Senate Resolution No.

adults103Introduced livingby withSenator TDBlakespear(Coauthors: remain undiagnosed, and even mild TD symptoms can be stigmatizing and impair physical, social, and emotional well-being, underscoring the urgency of early screening, detection, and intervention;

andSenators SR0105Alvarado-Gil, -2-Archuleta, LRB104Jones, 10584Laird, LAWNiello, 20660 r WHEREAS, The American Psychiatric Association recommends routine TD screening in their clinical guidelines for antipsychotic treatment, and individualsUmberg)April 27, 2026 treatedRelative with antipsychotics or experiencing abnormal movements should consult their health care providers to assessTardive TDDyskinesia risk,Awareness receiveWeek.LEGISLATIVE TDCOUNSEL'S screenings,DIGESTSR and103, determineBlakespear. appropriate treatment together;

andDigest WHEREAS,KeyBill FDA-approvedTextWHEREAS, treatmentsSerious formental TDillnesses canlike providebipolar optionsdisorder, formajor symptomdepressive managementdisorder, and improvedschizophrenia qualityoften ofrequire lifetreatment with antipsychotic medications for manyeffective individualsmanagement, livingand withantipsychotic TD;prescribing rates continue to rise;

andandWHEREAS, WHEREAS,While Theprolonged Generalantipsychotic Assemblyuse canmay encouragebe TDessential screeningfor educationthe andtreatment awarenessof forcertain healthconditions, careit providers,is patients,associated andwith caretardive partnersdyskinesia to(TD), helpa ensurecondition patientsmarked prescribedby antipsychoticsuncontrollable, receiveabnormal, care and supportrepetitive thatmovements alignsof withthe clinicalface, besttorso, practices,limbs, includingor regularextremities; TD screenings;

therefore,andWHEREAS, bePeople itat RESOLVED,higher BYrisk THEof SENATETD OFinclude THEthose ONE55 HUNDREDyears FOURTHof GENERALage ASSEMBLYor OFolder, THEBlack STATEindividuals, OFwomen, ILLINOIS,individuals thatwith wemood declareor Maysubstance 4use throughdisorders, Mayintellectual 10,disabilities, 2025or ascentral Tardivenervous Dyskinesiasystem Awarenessinjuries, Weekand (TDAW)those inwith thehigh Statecumulative ofantipsychotic Illinois;exposure;

andandWHEREAS, beApproximately it60 furtherpercent RESOLVED,of Thatthe weestimated support800,000 TDAWadults in recognition of the importanceUnited ofStates early detection and intervention to improve SR0105 -3- LRB104 10584 LAW 20660 r outcomes for people living with mentalTD healthremain conditionsundiagnosed, and prescribedeven antipsychotics,mild andTD wesymptoms supportcan effortsbe tostigmatizing raiseand awarenessimpair aboutphysical, thesocial, causes and symptomsemotional ofwell-being, tardiveunderscoring dyskinesia (TD) and the importanceurgency of routineearly TDscreening, screening.detection, and intervention;

andWHEREAS, The American Psychiatric Association recommends routine TD screening in their clinical guidelines for antipsychotic treatment, and individuals treated with antipsychotics or experiencing abnormal movements should consult their health care providers to assess TD risk, receive TD screenings, and determine appropriate treatment together;

andWHEREAS, Treatments approved by the United States Food and Drug Administration for TD can provide options for symptom management and improved quality of life for many individuals living with TD;

andWHEREAS, California can encourage TD screening education and awareness for health care providers, patients, and care partners to help ensure patients prescribed antipsychotics receive care and support that aligns with clinical best practices, including regular TD screenings;

now, therefore, be itResolved by the Senate of the State of California, That the Senate proclaims the first full week in May 2026 as “Tardive Dyskinesia Awareness Week” (TDAW), and, in recognition and support of TDAW, underscores the importance of early detection and intervention to improve outcomes for people living with mental health conditions and prescribed antipsychotics and supports efforts to raise awareness about the causes and symptoms of TD and the importance of routine TD screening;

and be it furtherResolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.